PAM50 classification is a method characterized by 5 intrinsic molecular subtypes according to the microarray-based gene expression profiling of BC patients, including the luminal A (LumA), luminal B (LumB), HER2-enriched (HER2-E), basal-like, and normal-like breast cancer subtypes [39, 54]. This evidence concerns the gene ERBB2 and breast cancer.